Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

6,775 total articles

Garrett Motion Showcases Breakthrough Oil-Free Centrifugal Compressor Portfolio at China Refrigeration Expo 2026

Garrett Motion Showcases Breakthrough Oil-Free Centrifugal Compressor Portfolio at China Refrigeration Expo 2026

Garrett Motion Inc. introduces a new portfolio of oil-free centrifugal compressors designed for data centers, battery energy storage systems, and industrial/commercial cooling markets. These compressors offer enhanced energy efficiency, reduced maintenance, and accommodate ultra-low-GWP refrigerants, positioning Garrett as a leader in next-generati…

Telix Strengthens Board with Additional Director Appointments

Telix Strengthens Board with Additional Director Appointments

Telix Pharmaceuticals Limited announces the appointment of two distinguished Non-Executive Directors, Maria Rivas, MD, and William Jellison, effective May 2026, to enhance the Board's expertise in US public company governance, clinical development, and financial oversight. This strategic expansion supports Telix's evolution as a dual-listed global …

SPX Technologies to Report First Quarter 2026 Financial Results

SPX Technologies to Report First Quarter 2026 Financial Results

SPX Technologies, Inc., a diversified global supplier specializing in engineered products for HVAC and detection markets, announced it will report its first quarter fiscal 2026 financial results on April 30, 2026, after U.S. markets close. The company will host a webcasted conference call to discuss the results and business outlook.

LAX Transforms the Travel Experience with Daktronics Video Display System Upgrade at Tom Bradley International Terminal

LAX Transforms the Travel Experience with Daktronics Video Display System Upgrade at Tom Bradley International Terminal

Daktronics has been chosen by Los Angeles World Airports to provide a comprehensive upgrade to digital displays at LAX's Tom Bradley International Terminal. The project features over 30 integrated LED displays covering more than 15,000 square feet, enhancing traveler experience with cutting-edge visual technology. Installation will continue through…

First Fed Bank names Jennifer Gribble as Chief People Officer

First Fed Bank names Jennifer Gribble as Chief People Officer

First Northwest Bancorp, a Nasdaq-listed financial holding company and parent of First Fed Bank, announced the appointment of Jennifer Gribble as Chief People Officer, effective March 31, 2026. Gribble, an experienced HR leader, will lead talent acquisition, engagement, and organizational transformation initiatives to support the bank's modernizati…

AtaiBeckley’s BPL-003 Shows Rapid, Durable Antidepressant Response in Treatment-Resistant Depression Patients on SSRIs; Phase 2a Data Published in CNS Drugs

AtaiBeckley’s BPL-003 Shows Rapid, Durable Antidepressant Response in Treatment-Resistant Depression Patients on SSRIs; Phase 2a Data Published in CNS Drugs

AtaiBeckley Inc. announced positive Phase 2a clinical trial results showing that a single intranasal dose of BPL-003 achieved rapid (Day 2) and durable antidepressant responses in treatment-resistant depression patients who were also on stable SSRI therapy. The drug, which holds FDA Breakthrough Therapy Designation, was well tolerated with fast pat…

Eagle Bancorp Announces Earnings Call on April 23, 2026

Eagle Bancorp Announces Earnings Call on April 23, 2026

Eagle Bancorp, Inc., a Nasdaq-listed community bank holding company based in Bethesda, Maryland, announced its upcoming Q1 2026 earnings call. The company will release its financial results after market close on April 22, 2026, with a teleconference involving the CEO and CFO scheduled the next morning. The event will be accessible via telephone and…

Ascendis Pharma to List Ordinary Shares Directly on Nasdaq

Ascendis Pharma to List Ordinary Shares Directly on Nasdaq

Ascendis Pharma announced that it will directly list its ordinary shares on Nasdaq starting April 20, 2026, exchanging all existing American Depositary Shares (ADSs) for ordinary shares at a one-for-one ratio. This move aims to simplify the company's listing structure, potentially increase institutional ownership, improve liquidity, and facilitate …

Endeavour Silver Produces 1,875,375 Oz Silver and 11,740 Oz Gold, for a total of 3.3 Million Silver Equivalent Oz in Q1 2026

Endeavour Silver Produces 1,875,375 Oz Silver and 11,740 Oz Gold, for a total of 3.3 Million Silver Equivalent Oz in Q1 2026

Endeavour Silver Corp. announced Q1 2026 production results, delivering 1,875,375 oz of silver, 11,740 oz of gold, and 3.3 million silver equivalent ounces boosted by mine expansions and improved recoveries across key sites including Terronera, Guanaceví, and Kolpa. Despite some weather-related and operational challenges, the company achieved signi…

FactSet Announces Chief Financial Officer Transition

FactSet Announces Chief Financial Officer Transition

FactSet announced the appointment of Joshua B. Warren as Chief Financial Officer effective April 13, 2026, replacing Helen Shan. Warren brings significant experience in asset management, fintech, and capital markets leadership. The transition is part of FactSet's ongoing strategic evolution, with the company emphasizing continuity and growth in dat…

Climb Bio to Host R&D Spotlight Webcast Highlighting Budoprutug and the CD19 Opportunity on May 5, 2026

Climb Bio to Host R&D Spotlight Webcast Highlighting Budoprutug and the CD19 Opportunity on May 5, 2026

Climb Bio, a clinical-stage biotech company focused on immune-mediated diseases, announced an R&D Spotlight webcast on May 5, 2026, highlighting their budoprutug program, an anti-CD19 monoclonal antibody in clinical trials for diseases such as primary membranous nephropathy, immune thrombocytopenia, and systemic lupus erythematosus. The webcast wil…

BioXcel Therapeutics Announces Enrollment of First Patients in U.S. Department of War-Funded Study of BXCL501 (Sublingual Dexmedetomidine) for Treatment of Acute Stress Reactions

BioXcel Therapeutics Announces Enrollment of First Patients in U.S. Department of War-Funded Study of BXCL501 (Sublingual Dexmedetomidine) for Treatment of Acute Stress Reactions

BioXcel Therapeutics has enrolled the first patients in a U.S. Department of War-funded Phase 2a clinical trial investigating its investigational drug BXCL501 (sublingual dexmedetomidine) for the treatment of acute stress reactions (ASR). The study, led by University of North Carolina at Chapel Hill's Institute for Trauma Recovery, aims to evaluate…